Febuxostat Tablets Market

The main component of non-bubuxostat is non-bubuxostat, and its chemical name is 2-[(3-cyanogroup - 4-isobutyl oxygen group) phenyl] -4-methyl-5-thiazole carboxylic acid.Xanthine oxidase (XO) inhibitor for the long-term treatment of hyperuricemia with gout symptoms.

Febuxostat Tablets Market contains market size and forecasts of Febuxostat Tablets in global, including the following market information:

Global Febuxostat Tablets Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Febuxostat Tablets Market Sales, 2017-2022, 2023-2028, (M Pcs)

Global top five Febuxostat Tablets companies in 2021 (%)

The global Febuxostat Tablets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

40 Mg Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Febuxostat Tablets include Menarini Group, Takeda Pharmaceuticals, MACLEODS, Prinston Pharmaceutical, Alembic Pharmaceuticals, Hikma Pharmaceuticals, Lupin Limited, Mylan and Teijin Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Febuxostat Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Febuxostat Tablets Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Febuxostat Tablets Market Segment Percentages, by Type, 2021 (%)

40 Mg Tablet

80 Mg Tablet

120 Mg Tablet

20 Mg Tablet

Global Febuxostat Tablets Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Febuxostat Tablets Market Segment Percentages, by Application, 2021 (%)

Hyperuricemia

Tumor Lysis Syndrome

Angina Pectoris

Other

Global Febuxostat Tablets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Febuxostat Tablets Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Febuxostat Tablets revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Febuxostat Tablets revenues share in global market, 2021 (%)

Key companies Febuxostat Tablets sales in global market, 2017-2022 (Estimated), (M Pcs)

Key companies Febuxostat Tablets sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Menarini Group

Takeda Pharmaceuticals

MACLEODS

Prinston Pharmaceutical

Alembic Pharmaceuticals

Hikma Pharmaceuticals

Lupin Limited

Mylan

Teijin Pharma

Hengrui Pharma

Sun Pharma

Msn Laboratories

Golden State Medical

Novadoz Pharmaceuticals

Astellas Pharma

SK Holdings

Ipsen

Hangzhou Zhuyangxin Pharmaceutical

Jiangsu Wanbang Biochemical Pharmaceutical Group

Tianjin Pacific Pharmaceutical